Ginkgo Bioworks Schedules Q2 2026 Business Review & Q&A

What Happened

• Ginkgo Bioworks Holdings, Inc. filed a Form 8-K on July 30, 2026 announcing it will host a presentation and live Q&A reviewing its business performance for the quarter ended June 30, 2026. The session is scheduled for Wednesday, August 5, 2026 at 4:30 p.m. ET and will be webcast on Ginkgo’s investor relations website; a replay will be posted afterward. Shareholders can submit questions in advance via X (hashtag #GinkgoResults) or by email to investors@ginkgobioworks.com.

Key Details

• Filing date: July 30, 2026 (Form 8-K).
• Event: Presentation and Q&A on Aug. 5, 2026 at 4:30 p.m. ET covering Q2 (quarter ended June 30, 2026) business performance and quarterly results.
• Access: Live webcast and replay on Ginkgo’s investor relations site; advance questions accepted via X (#GinkgoResults) or email.
• Company disclosure channels include SEC filings, the corporate and investor relations websites, news site, blog, and social media.

Why It Matters

• This is a scheduled investor update where management will review the company’s recent quarterly results and business performance—important for shareholders tracking earnings, revenue trends, and operational progress. The webcast and multiple disclosure channels give investors direct access to the presentation and a chance to ask questions in advance, which can help clarify near-term performance and strategy without waiting for formal earnings materials.